134 results
Page 2 of 7
8-K
EX-99.1
86oy6wc9
4 Aug 22
Madrigal Pharmaceuticals Provides Clinical and Business Updates and Reports 2022 Second Quarter Financial Results
6:33am
8-K
EX-99.1
ypapaemd bxp
4 Nov 21
Madrigal Pharmaceuticals Provides Corporate Update and Reports 2021 Third Quarter Financial Results
8:30am
8-K
EX-99.1
sjtp z185w
5 Aug 21
Madrigal Pharmaceuticals Reports 2021 Second Quarter Financial Results and Provides Corporate Update
8:31am
424B5
le4llmq3v8tib sf6g
1 Jun 21
Prospectus supplement for primary offering
7:31am
8-K
EX-99.1
a4obx5ykrt ua
6 May 21
Madrigal Pharmaceuticals Reports 2021 First Quarter
8:31am
DEFA14A
fos47ztvj
30 Apr 21
Additional proxy soliciting materials
4:04pm
8-K
EX-99.1
84dot2j
25 Feb 21
Madrigal Pharmaceuticals Reports 2020 Fourth Quarter
8:58am
424B5
m6623y31b5rv8c0z
5 Nov 20
Prospectus supplement for primary offering
9:39am
8-K
EX-99.1
pmff4ruo63
5 Nov 20
Madrigal Pharmaceuticals Announces Completion of Enrollment in Phase 3 MAESTRO NAFLD-1 Trial and Reports 2020 Third Quarter
8:52am
8-K
EX-99.1
cbaydu2w9sd 4x
6 Aug 20
Madrigal Pharmaceuticals Reports 2020 Second Quarter
8:50am